ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

Biorepository and Processing services

GENOMICS ENGLAND LIMITED · Contract details notice on Find a Tender

Tender information last checkedLast checked 2 Oct 2026, 14:36.

Opportunity overview

The services cover end‑to‑end management of biological samples, including receipt, verification and secure storage in controlled ultra‑low‑temperature environments. Samples are processed through a range of laboratory workflows that include DNA and RNA extraction, quality control testing, normalisation, and preparation for downstream sequencing all delivered on a per‑sample basis, there is no fixed maximum number of samples. Additional activities include aliquoting, pooling, reformatting into required labware, and arranging shipments to designated laboratories. Project‑specific workflows may be developed to meet bespoke requirements.

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

UK BIOCENTRE LIMITED

Matched by number
Contract value
£1.8m
Awarded
Not supplied
Contract signed
29 Sept 2026
Including VAT
£2.2m
Award ID
1
Status
active
Identifier
GB-COH 07618653
Location
Milton Keynes, UKJ12, MK7 8AT, United Kingdom

Classification

No classification was supplied.

Lots

  • Lot 1Value not stated

Documents and notices

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
GEL-HE-25732
Status
complete
Procurement Method
direct
Procurement Method Details
Direct award
Why this procedure was chosen
The delivery of services under a new contract with the existing supplier is proposed in accordance with Schedule 5, Paragraph 7 of the Procurement Act 2023, which enables a direct award where a change of supplier would result in incompatible goods or services and where such incompatibility would give rise to disproportionate technical difficulties in operation or maintenance. The remaining activity represents a continuation of established work already underway within the programme, and the new contractual arrangement does not introduce any additional or materially altered services. Transitioning to an alternative supplier at this stage would require substantial changes to embedded methodologies, operational processes and systems integration, resulting in significant incompatibilities with the established technical approach. Crucially, a change of supplier would also necessitate the transportation of a substantial volume of biological samples to a new provider. This introduces a material and unacceptable risk of contamination, loss, degradation or compromise of sample integrity, given the heightened handling requirements, increased logistical steps, and the sensitivity of the sample types involved. Such risks would directly threaten the comparability, consistency and scientific validity of programme outputs. Managing these transportation risks-alongside the need to migrate complex datasets, workflows and sample handling processes-would introduce disproportionate technical difficulties, as anticipated under Schedule 5, Paragraph 7, and would undermine the robustness of the study's established operational and analytical frameworks. Maintaining service delivery with the incumbent supplier therefore ensures continuity of technical methodologies, operational processes and quality controls, safeguarding the reliability and stability of the remaining programme work. In these circumstances, awarding a new contract to the existing supplier meets the criteria under Schedule 5, Paragraph 7, as a change in supplier would result in incompatible services and introduce unreasonable and disproportionate technical and logistical difficulties. The direct award is therefore the most appropriate, proportionate and compliant procurement route under the Procurement Act 2023.

Legal basis

Id
2023/54
Scheme
UKPGA

Procedure reasons

Entry 1
Id
additionalRepeatExtensionPartialReplacement

Lots and requirements

Entry 1
Id
1
Status
complete

Published documents

Entry 1
Id
conflictOfInterest
Document Type
conflictOfInterest
Description
Not published

Buyer, suppliers and contacts

Organisation 1
Name
GENOMICS ENGLAND LIMITED
Id
GB-COH-08493132

Identifier

Scheme
GB-COH
Id
08493132

Additional Identifiers

Entry 1
Scheme
GB-PPON
Id
PBTW-5897-QJGY

Address

Street Address
Level 21 One Canada Square
Locality
London
Postal Code
E14 5AB
Country
GB
Country Name
United Kingdom
Region
UKI42

Contact

Roles

buyer

Details

Classifications

Entry 1
Scheme
UK_CA_TYPE
Id
publicAuthorityCentralGovernment
Description
Public authority - central government
Organisation 2
Name
UK BIOCENTRE LIMITED
Id
GB-COH-07618653

Identifier

Scheme
GB-COH
Id
07618653

Additional Identifiers

Entry 1
Scheme
GB-PPON
Id
PYHJ-9527-GHDD

Address

Street Address
Units 2 & 3, Java Park Bradbourne Drive
Locality
Milton Keynes
Postal Code
MK7 8AT
Country
GB
Country Name
United Kingdom
Region
UKJ12

Contact

Roles

supplier

Details

Scale
large
Vcse
No
Public Service Mission Organization
No
Sheltered Workshop
No

Award information

Award 1
Id
1
Status
active
Main Procurement Category
services

Items

Item 1
Id
1
Related Lot
1

Additional Classifications

Entry 1
Scheme
CPV
Id
85111810
Description
Blood analysis services

Suppliers

Supplier 1
Id
GB-COH-07618653
Name
UK BIOCENTRE LIMITED

Related lots

1

Contracts and changes

Entry 1
Id
1
Award ID
1
Title
GEL-HE-25372 Biorepository and Processing services
Status
active
Has Options
Yes
Above Threshold
Yes
Date Signed
30 Sept 2026, 00:00
No Agreed Metrics Rationale
KPIs have been included within the contract, however the contract value does not reach the relevant threshold therefore publication is not necessary.

Period

Starts
30 Sept 2026, 00:00
Ends
31 Mar 2028, 23:59

Options

Description
The contract does not provide an automatic or unilateral right to make additional purchases; however, it does enable further services or increased volumes to be added through its formal Change Control procedure. Under the formal Change Control Procedure, any expansion of scope-such as additional processing, storage capacity, new workflows, or increased sample batching volumes-must be requested, assessed, and mutually agreed by both parties before becoming contractually binding. This mechanism allows the Authority to procure additional work when needed but only through a structured and approved variation to the existing services.

Value

Including VAT
2,212,197.6
Amount
1,843,498
Currency
GBP

Documents

Entry 1
Id
093354-2026
Document Type
contractNotice
Notice Type
UK7
Description
Contract details notice on Find a Tender
Published
2 Oct 2026, 13:29
Format
text/html

Recorded locations

  • Buyer location · London · UKI42 · E14 5AB · United Kingdom

Notice and amendment history

3 published notice versions reviewed by ProcuraAxis.

3 VERSIONS
  1. 013933-2026Transparency notice on Find a Tender ·
  2. 015976-2026Contract award notice on Find a Tender ·
  3. 093354-2026Contract details notice on Find a Tender ·